16th August 2022 Merck and Orna Therapeutics Collaborate to Advance Orna’s Next Generation of RNA Technology
16th August 2022 Orna Therapeutics Raises $221 Million Series B Financing to Advance Circular RNA Platform, Accelerate Programs to the Clinic
2nd June 2022 Repare Therapeutics Announces a Worldwide License and Collaboration Agreement with Roche for Camonsertib (RP-3500)
